The role of nitric oxide in vascular headache

被引:24
作者
van der Kuy, PHM [1 ]
Lohman, JJHM
机构
[1] Univ Limburg, Acad Hosp Maastricht, Dept Clin Pharm & Toxicol, Maastricht, Netherlands
[2] Maasland Hosp, Dept Clin Pharm Clin Pharmacol & Toxicol, Sittard, Netherlands
来源
PHARMACY WORLD & SCIENCE | 2003年 / 25卷 / 04期
关键词
experimental vascular headache; histamine; migraine; nitric oxide; nitroglycerin; NO-cGMP pathway; vascular headache;
D O I
10.1023/A:1024800512790
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Shortly after the invention of nitroglycerin (NTG), it was noticed that this substance is capable of inducing a violent headache. Only recently, it became known that this was due to the release of nitric oxide ( NO) by NTG. As the molecular mechanism of migraine pain remains to be determined, NTG, being pro-drug for NO, has been used to study the aetiology and pathophysiology of migraine. Such studies with NTG- and also histamine-induced headaches, have led to propose that NO may be the causative molecule in migraine pain. The evidence supporting the role of NO in migraine is discussed, e. g. substances capable of inducing experimental vascular headache do so with NO as the common mediator, while drugs with antimigraine activity inhibit NO and the cascade of intracellular reactions triggered by NO. The importance of NO as a potential initiator of the migraine attack opens new directions for the pharmacological treatment of migraine and other vascular headaches.
引用
收藏
页码:146 / 151
页数:6
相关论文
共 57 条
[1]   HEADACHE PROVOCATION BY CONTINUOUS INTRAVENOUS-INFUSION OF HISTAMINE - CLINICAL-RESULTS AND RECEPTOR MECHANISMS [J].
AEBELHOLTKRABBE, A ;
OLESEN, J .
PAIN, 1980, 8 (02) :253-259
[2]  
Alvarez W.C., 1940, MAYO CLIN, V15, P616, DOI [10.1097/00000542-194101000-00028, DOI 10.1097/00000542-194101000-00028]
[3]   HIGH PREVALENCE OF MIGRAINE IN A HIGH-ALTITUDE POPULATION [J].
ARREGUI, A ;
CABRERA, J ;
LEONVELARDE, F ;
PAREDES, S ;
VISCARRA, D ;
ARBAIZA, D .
NEUROLOGY, 1991, 41 (10) :1668-1670
[4]   Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial [J].
Ashina, M ;
Lassen, LH ;
Bendtsen, L ;
Jensen, R ;
Olesen, J .
LANCET, 1999, 353 (9149) :287-289
[5]   Endogenous nitric oxide synthesis: Biological functions and pathophysiology [J].
Bredt, DS .
FREE RADICAL RESEARCH, 1999, 31 (06) :577-596
[6]   INDUCTION OF MIGRAINE-LIKE HEADACHES BY THE SEROTONIN AGONIST META-CHLOROPHENYLPIPERAZINE [J].
BREWERTON, TD ;
MURPHY, DL ;
MUELLER, EA ;
JIMERSON, DC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (06) :605-609
[7]  
BRUNTON L, 1908, THERAPEUTICS CIRCULA
[8]   CLUSTER HEADACHE - TRANSCRANIAL DOPPLER ULTRASOUND AND RCBF STUDIES [J].
DAHL, A ;
RUSSELL, D ;
NYBERGHANSEN, R ;
ROOTWELT, K .
CEPHALALGIA, 1990, 10 (02) :87-94
[9]   NITROGLYCERIN AS A PROVOCATIVE AGENT IN CLUSTER HEADACHE [J].
EKBOM, K .
ARCHIVES OF NEUROLOGY, 1968, 19 (05) :487-&
[10]   ON SEROTONIN AND MIGRAINE - A CLINICAL AND PHARMACOLOGICAL REVIEW [J].
FERRARI, MD ;
SAXENA, PR .
CEPHALALGIA, 1993, 13 (03) :151-165